[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340100-105":59,"doc-detail-340100-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","progress-and-perspective-of-organoid-technology-in-breast-cancer-research-review-and-prospects","Progress and Perspective of Organoid Technology in Breast Cancer Research - Review and Prospects","","Breast cancer remains common among women worldwide, yet traditional in vitro models often fail to reproduce the biological functions of tumors in vivo. Organoid models offer distinct advantages over conventional approaches such as cell culture and patient-derived xenografts. By combining organoids with emerging tools including gene engineering and microfluidic chip technologies, research can offset organoid limitations and improve translational value. This review evaluates merits and drawbacks versus traditional models, summarizes recent technology-or-organoid integrations, and discusses construction methods and future applications for diverse breast cancer organoid systems.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/progress-and-perspective-of-organoid-technology-in-breast-cancer-research-review-and-prospects/340100/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/progress-and-perspective-of-organoid-technology-in-breast-cancer-research-review-and-prospects/340100.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How do gene engineering and microfluidic chip technologies improve organoid-based breast cancer research?","Question",{"text":112,"@type":113},"Genetic engineering enables experimental research and drug development with modified organoids. Microfluidic chip technology can partially compensate for the lack of vascular systems in organoids.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},340100,1790475412,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":41,"preview_page_count":19,"preview_urls":137},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Progress and perspective of organoid technology in breast cancer research  \nChangsheng Huang, Hongyan Jin  \nDepartment of Obstetrics and Gynecology, Peking University First Hospital , Beijing 100034 , China.  \nAbstract  \nBreast cancer, a malignant tumor with a high incidence in women, lacks in vitro research models that can represent the biological functions of breast tumors in vivo. As a new biological tool, the organoid model has unique advantages over traditional methods, such as cell culture and patient-derived xenografts. Combining organoids with other emerging technologies, such as gene engineering and microfluidic chip technology, provides an effective method to compensate for the deficiencies in organoid models of breast cancer in vivo. The emergence of breast cancer organoids has provided new tools and research directions in precision medicine, and drug research. In this review, we summarized the merits and demerits of organoids compared to traditional biological models, explored the latest developments in the combination of new technologies and organoid models, and discussed the construction methods and application prospects of different breast cancer organoid models.  \nKeywords: Organoids; Breast cancer; Preclinical model; Bioengineering  \nIntroduction  \nSince 2020, breast cancer has surpassed lung cancer asthe most common malignancy worldwide, and is one of the most common causes of death among women. [1] In recent years, the incidence of breast cancer in our country has increased annually and the age of affected women has tended to decrease. In China, breast cancer is most common among people in their 40s and 50s, with an average age of 48–49 years, more than 10 years younger than that reported in Western countries. [2] Although the progesterone receptor (PR ), estrogen receptor (ER ), and human epidermal growth factor receptor 2 (HER2) are commonly used to type and to guide the treatment of the breast cancer, there are hundreds of genes related to breast cancer. [3] The diversity of mutated genes and individual differences among patients are the reasons for the failure of breast cancer treatment. The pathogenesis of breast cancer has not been fully elucidated and the risk factors affecting the occurrence of breast cancer are varied. [4] Therefore, an accurate treatment for patients with breast cancer has become a popular research topic.  \nThe selection of an appropriate biological model is the basis for studying the pathogenesis of breast cancer. Common biological models include two-dimensional  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code:\u003Cbr>| Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10. 1097/CM9 .0000000000002889 |\n\n(2D) cell culture models, patient-derived xenograft (PDX) models, and organotypic tissue slice cultures (OTSCs) . The 2D model is simple, but cannot fully reflect the reactions of the human body. Although PDX models preserve the biological and molecular characteristics of patient tumors well, their shortcomings, such as high experimental costs and long experimental periods, limit their large-scale application. OTSCs have both advantages; however, they cannot be preserved for a long time and do not reflect the regenerative potential of the tumor. Therefore, there is an urgent need for a model that can simulate the biological functions of tumors in the human body.  \nRecently, emerging organoids have become a focus of research. Organoids are three-dimensional (3D ) structures with multicellular complexity and some degrees of tissue structure and function. They are characterized by the stable proliferation and fast construction speed, can be frozen to form biobanks, and can be derived from patient tissues. Research on breast cancer organoids is rapidly developing. Embryonic and induced pluripotent stem cells (iPSCs) can be used to culture breast cancer organoids to study the growth and development of breast cancer and disease occurrence. [5]  \nIn contrast, breast","cbCaiujKpmL3BIm1","https://ap.wps.com/l/cbCaiujKpmL3BIm1","pdf",644167,12,"English","# Introduction\n## Biological model selection\n## Limits of 2D culture, PDX, and OTSCs\n# Organoid technology overview\n## Key features and development\n# Merits and demerits of biological models","[{\"question\":\"How do gene engineering and microfluidic chip technologies improve organoid-based breast cancer research?\",\"answer\":\"Genetic engineering enables experimental research and drug development with modified organoids. Microfluidic chip technology can partially compensate for the lack of vascular systems in organoids.\"}]","Progress and Perspective of Organoid Technology in Breast Cancer Research - Review and Prospects | PDF",1790034185,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d9fdc8d4cdab448f23d3a12379e1658.webp",983,1324,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac97043dece8f3e74c29d0c27ec38e7e.webp",982,1322,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd225e00962af493db4ea188a241ce5c.webp",981,1321,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa207065130830c3757bb29be7c297c6.webp",980,1319]